The SBI Equity Hybrid Fund Regular Growth has an AUM of 74035.66 crores & has delivered CAGR of 18.77% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 1.40%.

Jazz Pharma has bolstered its pipeline of cancer drugs through a $1.3 billion licensing agreement with Werewolf Therapeutics that adds its first immuno-oncology candidate. The Dublin-based pharma ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Upcoming Movies and TV shows Rotten Tomatoes Podcast Media News + More ...